Clinical trial · Observational
Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study
Long Term Followup of Patients Enrolled in MC1137 (BEAUTY)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study gathers information and samples for further analysis as part of the BEAUTY study. The purpose of the BEAUTY study was to better understand the reasons why or why not breast cancers respond to standard chemotherapy. Collecting samples of blood and tissue and health and treatment information from patients on the BEAUTY study may help doctors identify changes that make cancer better respond to standard chemotherapy and develop better therapies for the treatment of cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Carcinoma | Breast Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biospecimen Collection | Procedure | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational (biospecimen collection, questionnaire)
- description
- Patients undergo collection of blood samples throughout the study. Patients may also complete questionnaires and undergo the collection of tissue samples throughout the study.
- interventionNames
- Procedure: Biospecimen Collection
- Other: Questionnaire Administration
Primary outcomes (8)
- measure
- Association of residual cancer burden and breast cancer disease-free interval
- timeFrame
- Up to 10 years following study entry
- measure
- Trajectory of CTC and ctDNA over time after breast cancer treatment
- timeFrame
- Up to 10 years following study entry
- description
- Using RareCyte CTC technology
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * REGISTRATION - FOR PATIENTS STILL ALIVE: * Enrolled in BEAUTY \[MC1137 (NCT02022202)\] and did not withdraw consent while enrolled on BEAUTY for either specimen collection or long-term follow-up * Able to provide written informed consent * REGISTRATION - FOR PATIENTS WHO HAVE DIED: * Enrolled in MC1137 and did not withdraw consent while enrolled on BEAUTY for either specimen collection or long-term follow-up * Existence of a family member willing to provide consent for use of archived tumor biopsies obtained after enrollment in BEAUTY
References
Publications (0)
Data not yet available